ARCHIVES

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

Last Issue Until Aug. 20

July 30, 1982

NCAB Committee Submits Drafts Of QRA Policy Statement

July 8, 1983

“Over-Regulation” Threatens Health Care, Thompson Says.

June 15, 2001

ACS Creates $1 Billion Nationwide Organization, Taking Fiduciary Control From 12 Divisions

November 18, 2011

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

July 28, 1995

NCI’s New Divisional Structure In Place, Next Step Is Review Of Labs, Branches

October 13, 1995